Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > You'll likely catch COVID-19 again and again.

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Jul 17, 2022 3:55pm

128 Views

Post# 34829997

RE:RE:RE:RE:You'll likely catch COVID-19 again and again.

StevenBirch wrote: Aren't we expecting an update sometime between now and the end of August on Covid testing?

99942Apophis wrote: Good idea Oden6570 might be better when we know there is progress on Theralase's front in their animal and human testing. We still don't know where or when funding will be available! Current money is needed for NMIBC in my opinion no matter how good a COVID-19 therapeutic/vaccine appears.

End of Sept at the latest? I agree with SF, if the animal model data looks good, it will lead to a $$ deal with PHAC.

<< Previous

Bullboard Posts

Next >>

Geologica Resource: Polymetallic upside at a depressed price